Rationale and design of Short-Term EXenatide therapy in Acute ischaemic Stroke (STEXAS): a randomised, open-label, parallel-group study

INTRODUCTION: Both hyperglycaemia and hypoglycaemia in acute ischaemic stroke (AIS) are associated with increased infarct size and worse functional outcomes. Thus, therapies that can maintain normoglycaemia during stroke are clinically important. Glucagon-like peptide 1 (GLP-1) analogues, including...

Descripción completa

Detalles Bibliográficos
Autores principales: McGrath, Rachel T, Hocking, Samantha L, Priglinger, Miriam, Day, Susan, Herkes, Geoffrey K, Krause, Martin, Fulcher, Gregory R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769437/
https://www.ncbi.nlm.nih.gov/pubmed/26911582
http://dx.doi.org/10.1136/bmjopen-2015-008203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769437/
https://www.ncbi.nlm.nih.gov/pubmed/26911582
http://dx.doi.org/10.1136/bmjopen-2015-008203

Ejemplares similares